| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2000 | EP1027335A1 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
| 08/16/2000 | EP1027333A1 Thrombin inhibitors |
| 08/16/2000 | EP1027332A1 Novel lactam metalloprotease inhibitors |
| 08/16/2000 | EP1027330A1 Styryl sulfone anticancer agents |
| 08/16/2000 | EP1027329A1 Dofetilide polymorphs |
| 08/16/2000 | EP1027328A1 Substituted anilides |
| 08/16/2000 | EP1027325A2 Lipophilic diesters of chelating agents |
| 08/16/2000 | EP1027093A1 Method and apparatus for applying 5-aminolevulinic acid |
| 08/16/2000 | EP1027069A1 Compositions and methods for treating lysosomal storage disease |
| 08/16/2000 | EP1027067A1 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes |
| 08/16/2000 | EP1027065A1 Method for destroying retinal pigment epithelial cells |
| 08/16/2000 | EP1027062A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide |
| 08/16/2000 | EP1027060A2 Use of macrolides for the treatment of cancer and macular degeneration |
| 08/16/2000 | EP1027058A1 Disaccharide derivatives for treating hyperglycaemia |
| 08/16/2000 | EP1027057A1 Treatment of female sexual dysfunction |
| 08/16/2000 | EP1027054A1 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 08/16/2000 | EP1027053A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 08/16/2000 | EP1027052A1 Novel combination |
| 08/16/2000 | EP1027051A1 Antithrombotic agents |
| 08/16/2000 | EP1027050A2 Adenosine a3 receptor antagonists |
| 08/16/2000 | EP1027049A1 Intranasal formulation containing scopolamine and method of treating motion sickness |
| 08/16/2000 | EP1027048A2 Selective cyclooxygenase-2 inhibitors against premature labor |
| 08/16/2000 | EP1027047A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 08/16/2000 | EP1027046A1 Antagonists of gonadotropin releasing hormone |
| 08/16/2000 | EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity |
| 08/16/2000 | EP1027044A1 Methods of treating and preventing endometriosis with phytoestrogens |
| 08/16/2000 | EP1027043A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
| 08/16/2000 | EP1027042A1 Inhibitors of farnesyl protein transferase |
| 08/16/2000 | EP1027040A2 Methods for modulating macrophage proliferation using polyamine analogs |
| 08/16/2000 | EP1027038A1 Taste masked pharmaceutical compositions |
| 08/16/2000 | EP1027037A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 08/16/2000 | EP1027036A2 Taste masked formulations |
| 08/16/2000 | EP1027033A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 08/16/2000 | EP1027029A1 Improved personal care formulations |
| 08/16/2000 | EP1027016A1 Methods and pharmaceutical compositions for the closure of retinal breaks |
| 08/16/2000 | EP1027015A1 Controlled release of pharmaceuticals in the anterior chamber of the eye |
| 08/16/2000 | EP1027011A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 08/16/2000 | EP1027004A1 Spine distraction implant |
| 08/16/2000 | EP1026959A1 Method for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant |
| 08/16/2000 | EP1026950A1 Treatment of schizophrenia with ampakines and neuroleptics |
| 08/16/2000 | EP1026947A1 Composition and method for treating penile erectile dysfunction |
| 08/16/2000 | EP0934325A4 Tetraphosphonate bicyclic trisanhydrides |
| 08/16/2000 | EP0925310B1 Use of sulfated polysaccharides for the treatment of a chronic wound |
| 08/16/2000 | EP0923379A4 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 08/16/2000 | EP0902790B1 Process for preparing steroids having a carboxamide side-chain |
| 08/16/2000 | EP0883628B1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof |
| 08/16/2000 | EP0877612B1 Use of piperazine derivatives for the treatment of cognitive disorders |
| 08/16/2000 | EP0869965B1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
| 08/16/2000 | EP0812589B1 Combined antipyretic analgesic drug |
| 08/16/2000 | EP0812194B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis |
| 08/16/2000 | EP0805802B1 Substituted phenyl compounds as endothelin antagonists |
| 08/16/2000 | EP0799193B1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid |
| 08/16/2000 | EP0799045B1 Treatment of hyperexcited nerve cell functions |
| 08/16/2000 | EP0768896B1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 08/16/2000 | EP0755922B1 22-thiavitamin d3 derivative |
| 08/16/2000 | EP0707481B1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 08/16/2000 | EP0690711B1 Taxanes having an amino substituted side-chain |
| 08/16/2000 | EP0667166B1 1-alpha,24-(oh)2-vitamin d3 emulsion composition |
| 08/16/2000 | EP0641204B1 17-ethers and thioethers of 4-aza-steroids |
| 08/16/2000 | EP0584108B1 Pharmaceutical composition comprising ibuprofen salt |
| 08/16/2000 | EP0463126B1 Methods of enhancing wound healing and tissue repair |
| 08/16/2000 | CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells |
| 08/16/2000 | CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 08/16/2000 | CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 08/16/2000 | CN1263533A New formulation |
| 08/16/2000 | CN1263532A 13-dihydro-3' aziridino anthracyclines |
| 08/16/2000 | CN1263529A Carbocyclic nucleoside hemisulfate and its use in treating viral infectiosn |
| 08/16/2000 | CN1263528A N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists |
| 08/16/2000 | CN1263527A Cis-disubstituted aminocycloalykyl-pyrrolidine derivatives |
| 08/16/2000 | CN1263522A Compounds and methods for inhibition of expression of VCAM-1 |
| 08/16/2000 | CN1263473A Composition and method for enhancing transport across biological membranes |
| 08/16/2000 | CN1263471A Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative |
| 08/16/2000 | CN1263468A Polyallylamine polymers for treating hypercholesterolemia |
| 08/16/2000 | CN1263467A Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 08/16/2000 | CN1263466A Solutions containing azasteroids |
| 08/16/2000 | CN1263465A Treatment and prevention of cardiac disorders using selective 5-hydroxytryptamine re-uptake inhibitors |
| 08/16/2000 | CN1263464A Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application |
| 08/16/2000 | CN1263463A Anti-chlamydia agent |
| 08/16/2000 | CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease |
| 08/16/2000 | CN1263461A Pharmaceutical composition |
| 08/16/2000 | CN1263454A Device and method for treatment of dysmenorrhea |
| 08/16/2000 | CN1263439A Nutritional composition for subjects under stress |
| 08/16/2000 | CN1263105A New saponin compound and its preparation method and application |
| 08/16/2000 | CN1263101A New derivative of erythromycin, its preparation method and medicinal application |
| 08/16/2000 | CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 08/16/2000 | CN1263093A Amlo dipine mesylate and its preparation and application |
| 08/16/2000 | CN1263087A Substituted alkyl tetramine derivative |
| 08/16/2000 | CN1262951A Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method |
| 08/16/2000 | CN1262935A Medicated wine for curing rheumatism and rheumatoid disease and its preparing method |
| 08/16/2000 | CN1262929A Medicine for curing schistosomiasis and its preparation method |
| 08/16/2000 | CN1262928A Application of bilirubin and its derivative as preparation for resisting influenza virus A1 type |
| 08/16/2000 | CN1262927A Dihydroartemisinin preparation for controlling broad-spectrum malaria and its preparation method |
| 08/16/2000 | CN1262925A Preparation method of microlipid granule for wrapping medicine |
| 08/16/2000 | CN1262922A Cosmetic or skin-protecting composition containing at least one kind of alkynyl carbamate and polyol |
| 08/16/2000 | CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
| 08/16/2000 | CN1055477C Intermediate compound for synthesizing nucleoside derivative |
| 08/16/2000 | CN1055474C Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]=6-amino-3-azabicyclo [3,1,0] hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl |
| 08/16/2000 | CN1055473C 1,9-bridged thiazolo (3,2-A) quinoline derivatives |
| 08/16/2000 | CN1055472C Oxazolo quinolyl-one derivatives, their preparation method and application and use as medicine |
| 08/16/2000 | CN1055471C Substituted imidazolidines, their preparing process, and intermediates, their pharmaceutical compositions and there use |